HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Revision periarterial sympathectomy for recurrent digital ischaemia: a report with 11 patients.

Abstract
Following periarterial sympathectomy, patients with recurrent digital ischemia due to vasospastic or vaso-occlusive disease have few remaining treatment options. We performed a retrospective review from 1997 to 2019 to determine the safety and efficacy of revision periarterial sympathectomy. Eleven patients were identified who underwent revision periarterial sympathectomy, performed on average 84 months after their initial procedure. Preoperatively, all patients had worsening ischemic pain and five had non-healing digital ulcers. Revision digital periarterial sympathectomy alone was performed in seven patients, while four had a more extensive sympathectomy. Mean follow-up after revision was 23 months (range 3 to 76). Eight patients had symptomatic improvement and four healed their digital ulcers. Three patients developed new ulcers during follow-up, of which two healed with conservative management and one required three digital amputations. Revision periarterial sympathectomy is effective in providing symptomatic improvement and digital ulcer healing with minimal postoperative complications.Level of evidence: IV.
AuthorsMegan Rudolph, Katherine Butler, Shamit Prabhu, Donald Browne, L Andrew Koman, Zhongyu Li
JournalThe Journal of hand surgery, European volume (J Hand Surg Eur Vol) Vol. 46 Issue 8 Pg. 883-890 (10 2021) ISSN: 2043-6289 [Electronic] England
PMID34107782 (Publication Type: Journal Article)
Topics
  • Arteries
  • Fingers (surgery)
  • Humans
  • Ischemia (etiology, surgery)
  • Retrospective Studies
  • Sympathectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: